Miragen Therapeutics's ticker is and the CUSIP is 60463E107. A total of 1 filers reported holding Miragen Therapeutics in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $90,366,000 | – | 12,891 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|